NI201800132A - Nuevos derivados piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen - Google Patents

Nuevos derivados piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen

Info

Publication number
NI201800132A
NI201800132A NI201800132A NI201800132A NI201800132A NI 201800132 A NI201800132 A NI 201800132A NI 201800132 A NI201800132 A NI 201800132A NI 201800132 A NI201800132 A NI 201800132A NI 201800132 A NI201800132 A NI 201800132A
Authority
NI
Nicaragua
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
piperidinyl derivatives
new piperidinyl
Prior art date
Application number
NI201800132A
Other languages
English (en)
Inventor
Kotschy ANDRÁS
Wéber Csaba
Vasas Attila
Molnár Balázs
Kiss Árpád
Macias Alba
Brooke Murray James
Lewkowicz Elodie
Geneste Olivier
Chanrion Maïa
Demarles Didier
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NI201800132A publication Critical patent/NI201800132A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Abstract

Compuestos de fórmula (I): en la que R1, R2, R3, n y W son como se han definido en la descripción. Medicamentos.
NI201800132A 2016-06-10 2018-12-07 Nuevos derivados piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen NI201800132A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1655392A FR3052452B1 (fr) 2016-06-10 2016-06-10 Nouveaux derives de piperidinyle, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
NI201800132A true NI201800132A (es) 2019-04-08

Family

ID=56943687

Family Applications (1)

Application Number Title Priority Date Filing Date
NI201800132A NI201800132A (es) 2016-06-10 2018-12-07 Nuevos derivados piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen

Country Status (45)

Country Link
US (1) US11046681B2 (es)
EP (1) EP3468974B1 (es)
JP (1) JP6928005B2 (es)
KR (1) KR20190016106A (es)
CN (1) CN109311888B (es)
AR (1) AR108706A1 (es)
AU (1) AU2017277734B2 (es)
BR (1) BR112018075433A2 (es)
CA (1) CA3027014C (es)
CL (1) CL2018003474A1 (es)
CO (1) CO2018013210A2 (es)
CR (1) CR20180564A (es)
CU (1) CU20180145A7 (es)
CY (1) CY1122870T1 (es)
DK (1) DK3468974T3 (es)
DO (1) DOP2018000270A (es)
EA (1) EA037211B1 (es)
EC (1) ECSP18090144A (es)
ES (1) ES2775789T3 (es)
FR (1) FR3052452B1 (es)
GE (1) GEP20207160B (es)
HR (1) HRP20200361T1 (es)
HU (1) HUE049507T2 (es)
IL (1) IL263463B (es)
LT (1) LT3468974T (es)
MA (1) MA45222B1 (es)
MD (1) MD3468974T2 (es)
ME (1) ME03670B (es)
MX (1) MX2018015216A (es)
MY (1) MY196562A (es)
NI (1) NI201800132A (es)
PE (1) PE20220567A1 (es)
PH (1) PH12018502515A1 (es)
PL (1) PL3468974T3 (es)
PT (1) PT3468974T (es)
RS (1) RS60029B1 (es)
RU (1) RU2743163C2 (es)
SG (1) SG11201810629QA (es)
SI (1) SI3468974T1 (es)
SV (1) SV2018005791A (es)
TN (1) TN2018000410A1 (es)
TW (1) TWI620750B (es)
UA (1) UA123794C2 (es)
UY (1) UY37288A (es)
WO (1) WO2017212012A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017155844A1 (en) 2016-03-07 2017-09-14 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
AU2018254577A1 (en) 2017-04-21 2019-12-05 Epizyme, Inc. Combination therapies with EHMT2 inhibitors
KR102556744B1 (ko) 2017-08-28 2023-07-18 이난타 파마슈티칼스, 인코포레이티드 B형 간염 항바이러스제
CA3083320C (en) 2017-11-29 2022-08-16 Les Laboratoires Servier Piperidinyl derivatives as inhibitors of ubiquitin specific protease 7
GB201801562D0 (en) 2018-01-31 2018-03-14 Almac Diagnostics Ltd Pharmaceutical compounds
UY38291A (es) * 2018-07-05 2020-06-30 Servier Lab Nuevos derivados de amino-pirimidonilo un proceso para su preparación y composiciones farmacéuticas
US10865211B2 (en) 2018-09-21 2020-12-15 Enanta Pharmaceuticals, Inc. Functionalized heterocycles as antiviral agents
UY38423A (es) * 2018-10-19 2021-02-26 Servier Lab Nuevos derivados amino-pirimidonil-piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen
WO2020106816A1 (en) 2018-11-21 2020-05-28 Enanta Pharmaceuticals, Inc. Functionalized heterocycles as antiviral agents
KR20210102285A (ko) * 2018-12-06 2021-08-19 알막 디스커버리 리미티드 약학적 화합물 및 유비퀴틴 특이적 단백질분해효소 19 (usp19)의 억제제로서의 사용
WO2020247444A1 (en) 2019-06-03 2020-12-10 Enanta Pharmaceuticals, Inc, Hepatitis b antiviral agents
US11760755B2 (en) 2019-06-04 2023-09-19 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
WO2020247575A1 (en) 2019-06-04 2020-12-10 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
US11738019B2 (en) 2019-07-11 2023-08-29 Enanta Pharmaceuticals, Inc. Substituted heterocycles as antiviral agents
WO2021055425A2 (en) 2019-09-17 2021-03-25 Enanta Pharmaceuticals, Inc. Functionalized heterocycles as antiviral agents
CN113087718B (zh) * 2020-01-09 2024-02-09 四川科伦博泰生物医药股份有限公司 噻吩并嘧啶酮类化合物及其医药应用
CN112608320B (zh) * 2020-01-16 2023-03-17 中国药科大学 哌啶类化合物及其制备方法和医药用途
GB202001980D0 (en) 2020-02-13 2020-04-01 Almac Discovery Ltd Therapeutic mentods
WO2021188414A1 (en) 2020-03-16 2021-09-23 Enanta Pharmaceuticals, Inc. Functionalized heterocyclic compounds as antiviral agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009521445A (ja) * 2005-12-21 2009-06-04 シェーリング コーポレイション H3アンタゴニスト/逆アゴニストと食欲抑制剤との組み合わせ
CN101674831A (zh) * 2007-03-02 2010-03-17 先灵公司 用于治疗糖尿病或疼痛的哌啶基哌啶和哌嗪基哌啶
EP2565186A1 (en) * 2011-09-02 2013-03-06 Hybrigenics S.A. Selective and reversible inhibitors of ubiquitin specific protease 7
TWI698436B (zh) * 2014-12-30 2020-07-11 美商佛瑪治療公司 作為泛素特異性蛋白酶7抑制劑之吡咯并及吡唑并嘧啶
PE20220948A1 (es) * 2016-06-10 2022-05-31 Servier Lab Nuevos derivados piperidinilo sustituidos con (hetero) arilo, un proceso para su preparacion y composiciones farmaceuticas que los contienen

Also Published As

Publication number Publication date
CU20180145A7 (es) 2019-07-04
IL263463B (en) 2021-01-31
PL3468974T3 (pl) 2020-07-13
EA201892838A1 (ru) 2019-06-28
MX2018015216A (es) 2019-04-25
DK3468974T3 (da) 2020-05-11
ME03670B (en) 2020-10-20
CA3027014C (en) 2021-01-05
ECSP18090144A (es) 2019-01-31
MD3468974T2 (ro) 2020-05-31
PH12018502515B1 (en) 2019-09-30
US11046681B2 (en) 2021-06-29
LT3468974T (lt) 2020-04-10
FR3052452B1 (fr) 2018-06-22
ES2775789T3 (es) 2020-07-28
PE20220567A1 (es) 2022-04-13
EP3468974A1 (en) 2019-04-17
JP6928005B2 (ja) 2021-09-01
PT3468974T (pt) 2020-03-25
EP3468974B1 (en) 2020-02-12
AU2017277734B2 (en) 2021-07-01
UY37288A (es) 2018-01-02
SG11201810629QA (en) 2018-12-28
WO2017212012A1 (en) 2017-12-14
FR3052452A1 (es) 2017-12-15
CO2018013210A2 (es) 2018-12-28
MA45222A (fr) 2019-04-17
RU2743163C2 (ru) 2021-02-15
CN109311888A (zh) 2019-02-05
SV2018005791A (es) 2019-01-16
RS60029B1 (sr) 2020-04-30
TW201802092A (zh) 2018-01-16
JP2019517556A (ja) 2019-06-24
BR112018075433A2 (pt) 2019-03-19
US20190144448A1 (en) 2019-05-16
CY1122870T1 (el) 2021-05-05
SI3468974T1 (sl) 2020-07-31
RU2018147430A (ru) 2020-07-10
EA037211B1 (ru) 2021-02-19
TN2018000410A1 (en) 2020-06-15
PH12018502515A1 (en) 2019-09-30
GEP20207160B (en) 2020-10-12
HUE049507T2 (hu) 2020-09-28
HRP20200361T1 (hr) 2020-06-12
CA3027014A1 (en) 2017-12-14
CR20180564A (es) 2019-03-04
AR108706A1 (es) 2018-09-19
TWI620750B (zh) 2018-04-11
AU2017277734A1 (en) 2018-12-20
MY196562A (en) 2023-04-19
DOP2018000270A (es) 2019-05-15
CN109311888B (zh) 2021-09-14
CL2018003474A1 (es) 2019-05-24
UA123794C2 (uk) 2021-06-02
KR20190016106A (ko) 2019-02-15
MA45222B1 (fr) 2020-04-30
RU2018147430A3 (es) 2020-07-10
IL263463A (en) 2019-01-31

Similar Documents

Publication Publication Date Title
NI201800132A (es) Nuevos derivados piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen
NI201800133A (es) Nuevos derivados piperidinilo sustituidos con (hetero) arilo, un proceso para su preparación y composiciones farmacéuticas que los contienen
NI201800076A (es) Nuevos derivados de amonio, un proceso para su preparación y composiciones farmacéuticas que los contienen
ECSP17083003A (es) Nuevos derivados bicíclicos, un proceso para su preparación y composiciones farmacéuticas que los contienen
ECSP17082825A (es) Nuevos derivados hidroxiácido, un proceso para su preparación y composiciones farmacéuticas que los contienen
ECSP17081744A (es) Nuevos derivados hidroxiéster,un proceso para su preparación y composiciones farmacéuticas que los contienen
CR20170590A (es) Nuevos derivados hidroxiácido, un proceso para su preparación y composiciones farmacéuticas que los contienen
CO7210068A1 (es) Nuevos derivados tienopirimidina, un proceso para su preparación y composiciones farmacéuticas que los contienen
DOP2018000082A (es) NUEVOS DERIVADOS DE PIRROLO[2,3-d]PIRIMIDINA, UN PROCESO PARA SU PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN
DOP2018000083A (es) NUEVOS DERIVADOS DE IMIDAZO[4,5-b]PIRIDINA, UN PROCESO PARA SU PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN
CL2021000973A1 (es) Nuevos derivados amino-pirimidonil-piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen.
SV2014004879A (es) Nuevos derivados tienopirimidina, un proceso para su preparación y composiciones farmacéuticas que los contienen